ENTITY
Hangzhou Tigermed Consulting

Hangzhou Tigermed Consulting (3347 HK)

192
Analysis
Health Care • China
Hangzhou Tigermed Consulting is a leading China-based contract research organization (CRO) providing comprehensive biopharmaceutical and medical device R&D services. The company offers a full suite of clinical research solutions, including clinical trial operations, data management, statistical analysis, medical writing, and regulatory affairs. It was founded in 2004 and is headquartered in Hangzhou, China.
more
Exchange Announcement • 09 Oct 2026 21:41

Adjustments To The List Of Participants And The Number Of Restricted Shares Granted Under The 2026 Restricted A Share Incentive Scheme And Grant Of Restricted Shares To Participants Under The 2026 Restricted A Share Incentive Scheme

Exchange Announcement • 25 Sep 2026 16:32

2026 Interim Report

Exchange Announcement • 23 Sep 2026 22:38

Articles Of Association

Exchange Announcement • 23 Sep 2026 22:36

Poll Voting Results Of The 2026 Third Extraordinary General Meeting, Third A Share Class Meeting And Third H Share Class Meeting Held On September 23, 2026

Exchange Announcement • 11 Sep 2026 22:27

Inside Information - Update On Investigation Against Directors And Controlling Shareholders

x